Ingevity (NGVT) Common Equity (2015 - 2026)

Ingevity (NGVT) has 12 years of Common Equity data on file, last reported at $38.9 million in Q1 2026.

• Quarterly Common Equity fell 83.42% year-over-year to $38.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.9 million (down 83.42% YoY) and the FY2025 annual result came in at $29.7 million, down 84.78% from the prior year.
• Common Equity advanced to $38.9 million in Q1 2026 per NGVT's latest filing, from $29.7 million in the prior quarter.
• Across five years, Common Equity topped out at $725.7 million in Q1 2023 and bottomed at $29.7 million in Q4 2025.
• The 5-year median for Common Equity is $568.2 million (2024), against an average of $428.7 million.
• The widest annual swing landed in 2023, when Common Equity advanced 13.38%; it then slumped 84.78% in 2025.
• Tracing NGVT's Common Equity over 5 years: stood at $698.3 million in 2022, then declined by 9.58% to $631.4 million in 2023, then tumbled by 69.08% to $195.2 million in 2024, then tumbled by 84.78% to $29.7 million in 2025, then surged by 30.98% to $38.9 million in 2026.
• Per Business Quant, the three latest NGVT Common Equity figures stand at $38.9 million (Q1 2026), $29.7 million (Q4 2025), and $138.1 million (Q3 2025).

Peer Comparison